Oral tolerization leads to active suppression and bystander tolerance in adult rats while anergy dominates in young rats

Scandinavian Journal of Immunology

Volumn 43, Issue 1, 1996, Pages 56-63

  Lundin, B S ^a   Dahlgren, U I H ^a   Hanson, L A ^a   Telemo, E ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

FREUND ADJUVANT; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; OVALBUMIN;

AGE; ANERGY; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SPLEEN CELL; SUBCUTANEOUS DRUG ADMINISTRATION; SUPPRESSOR CELL; T LYMPHOCYTE;

EID: 0030042438     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1996.d01-15.x     Document Type: Article

References (35)

1. Kagnoff MF. Effects of antigen-feeding on intestinal and systemic immune responses, II, Suppression of delayed type hypersensitivity reactions. J Immunol 1978;120:1509-13.
2. Hanson DG, Vaz NM, Maia L et al. Inhibition of specific immune responses by feeding protein antigens. Int Arch Allergy Appl Immun 1977;55:526-32.
3. Thomas HC, Parrot D. The induction of tolerance to a soluble protein antigen by oral administration. Immunology 1974; 27:631-39.
4. Strobel S, Ferguson A. Persistence of oral tolerance in mice fed ovalbumin is different for humoral and cell-mediated immune responses. Immunology 1987;60:317-18.
5. Whitacre CC, Gienapp IE, Orosz CG, Bitar DM. Oral tolerance in experimental autoimmune encephalomyelitis III. Evidence for clonal anergy. J Immunol 1991;147:2155-63.
6. Melamed D, Friedrnan A. Direct evidence for anergy in T lymphocytes tolerized by oral administration of ovalbumin. Eur J Immunol 1993;23:935-42.
7. Melamed D, Friedman A. In vivo tolerization of Th1 lymphocytes following a single feeding with ovalbumin: anergy in the absence of supppression. Eur J Immunol 1994;24:1974-81.
8. Chen Y, Inobe J, Marks R, Gonnella P, Kuchroo VK, Weiner HL. Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature 1995;376:177-80.
9. Miller SR, Hanson D. Inhibition of specific immune responses by feeding protein antigens. IV. Evidence for tolerance and specific active suppression of cell mediated immune responses to ovalbumin. J Immunol 1979;123:2344-50.
10. Miller A, Lider O, Roberts AB, Sporn MB, Weiner HL. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering. Proc Natl Acad Sci USA 1992;89:421-5.
11. - T effector cell. J Immunol 1983;131:2656-61.
12. Ngan J, Kind L. Suppressor T-cells for IgE and IgG in the Peyer's patches of mice made tolerant by oral administration of ovalbumin. J Immunol 1978;120:861-5.
13. Mattingly JA, Wakstnan B. Immunologic suppression after oral administration of antigen, I, Specific suppressor cells formed in rat Peyer's patches after oral administration of sheep erythrocytcs and their systemic migration. J Immunol 1978;121:1878-83.
14. Attallah AM, Ahmed A. Sell K. In vivo induction of carrier-specific cyclophosphamide sensitive suppressor cells for cell mediated immunity in mice. Int Arch Allergy Appl Immunol 1979;60:178-85.
15. Khoury SJ, Hancock WW, Weiner HL. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyclitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain. J Exp Med 1992;176:1355-64.
16. Miller A, al SA, Santos LM, Das MP, Weiner HL. Epitopes of myelin basic protein that trigger TGF-beta release after oral totalization are distinct from encephalitogenic epitopes and mediate epitope-driven bystander suppression. J Immunol 1993;151:7307-15.
17. Miller A, Lider O, Weiner H L. Antigen-driven bystander suppression after oral administration of antigens. J Exp Med 1991;174:791-8.
18. Bland P, Warren L. Antigen presentation by epithelial cells of the rat small intestine II. Selective induction of suppressor T cells Immunology 1986;58:9-14.
19. + T cell-dependent immune deviation resulting in selective suppression of immunoglobulin E production. J Exp Med 1993;178:889-99.
20. Friedman A, Weiner H L. Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proc Natl Acad Sci 1994;91:6688-92.
21. Gregerson DS, Obritsch WF, Donoso LA. Oral tolerance in experimental autoimmune uveorctinitis: distinct mechanisms of resistance are induced by low dose vs high dose feeding protocols. J Immunol 1993;151:5751-61.
22. Wold AE, Dahlgren UIH, Hanson LÄ, Mattsby-Baltzer I, Midtvetdt T. Difference between bacterial and food antigens in mucosal immunogenieity. Infect Immun 1989;57:2666-73.
23. Dahlman-Höglund A, Dahlgren UI, Ahlstedt S, Hanson LÅ, Telemo E, Bystander suppression of the immune response to human serum albumin in rats fed ovalbumin. Immunology 1995;86:128-33.
24. Williams NA, Wilson AD, Bailey M, Bland PW, Stokes CR. Primary antigen-specific T-cell proliferalive responses following presentation of soluble protein antigen by cells from the murine small intestine. Immunology 1992;75:608-13.
25. + counterparts in coeliac disease. Immunology 1990;71:460-6.
26. Brenan M, Puklavec M. The MRC OX-62 antigen: a useful marker in the purification of rat veiled cells with the biochemical properties of an integrin. J Exp Med. 1992;175:1457-65.
27. Mayrhofer G, Pugh CW, Barclay AN. The distribution, ontogeny and origin in the rat of Ia-positive cells with dedritie morphology and of Ia antigen in epithelia, with special reference to the intestine. Eur J Immunol 1983;13:112-22.
28. Gonnella PA, Wilmore DW. Co-localization of class II antigen and exogenous antigen in the rat enterocyte. J Cell Sci 1993;106:937-40.
29. Strobel S, Mowat AM, Drummond HE, Pickering MG, Ferguson A. Immunological responses to fed protein antigens in mice, II, Oral tolerance for CMI is due to activation of cyclophosphamide-sensitive cells by gut-processed antigen. Immunology 1983;49:451-6.
30. Bruce MG, Ferguson A. Oral tolerance to ovalbumin in mice: studies of chemically modified and "biologically filtered" antigen. Immunology 1986;57:627-30.
31. Bruce MG, Ferguson A. The influence of intestinal processing on the immunogenicity and molecular size of absorbed, circulating ovalbumin in mice. Immunology 1986;59:295-300.
32. Peng HJ, Turner MW, Strobel S. The generation of a "tolerogen" after ingestion of ovalbumin is time-dependent and unrelated to serum levels of immunoreactive antigen. Clin Exp Immunol 1990;81:510-15.
33. Telemo E, Bailey M, Miller BG, Stokes CR, Bourne FJ. Dietary antigen handling by mother and offspring. Scand J Immunol 1991;34:689-96.
34. Bailey M, Miller BG, Telemo E, Stokes CR, Bourne FJ. Specific immunological unresponsiveness following active primary responses to proteins in the weaning diet of piglets. Int Arch Allergy Immunol 1993;101:266-71.
35. Holt PG, McMenamin C. IgE and mucosal immunity: studies on the role of intraepithelial Ia + dendritic cells and gamma/delta T-lymphocytes in regulation of T-cell activation in the lung. Clin Exp Allergy 1991;1:148-52.